Table 4.
Prognostic Factors | Number | P value | 1-year | 3-year | 5-year | ||||
---|---|---|---|---|---|---|---|---|---|
| |||||||||
n | % | n | % | n | % | ||||
Age Range (years) | <0.001 | ||||||||
40 and below | 2 | 2 | 100 | 2 | 100 | 2 | 100 | ||
41-50 | 14 | 13 | 92.9 | 11 | 78.6 | 10 | 71.4 | ||
51-60 | 39 | 34 | 87.2 | 27 | 69.2 | 17 | 43.6 | ||
61-70 | 21 | 14 | 66.7 | 10 | 47.6 | 3 | 14.3 | ||
71-80 | 3 | 2 | 66.7 | 0 | 0 | 0 | 0 | ||
81 and above | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Blood Type | 0.009 | ||||||||
A | 32 | 26 | 81.3 | 18 | 56.3 | 9 | 28.1 | ||
B | 28 | 21 | 75.0 | 15 | 53.6 | 7 | 25.0 | ||
O | 14 | 13 | 92.9 | 12 | 85.7 | 12 | 85.7 | ||
AB | 6 | 5 | 83.3 | 5 | 83.3 | 4 | 66.7 | ||
Menopausal Status | 0.001 | ||||||||
Pre-menopausal | 24 | 20 | 83.3 | 17 | 70.8 | 17 | 70.8 | ||
Post-menopausal | 56 | 45 | 80.4 | 33 | 58.9 | 15 | 26.8 | ||
Clinical Stages | 0.0036 | ||||||||
I | 34 | 34 | 100.0 | 33 | 97.1 | 25 | 73.5 | ||
II | 6 | 6 | 100.0 | 4 | 66.7 | 3 | 50.0 | ||
III | 22 | 17 | 77.3 | 9 | 40.9 | 4 | 18.2 | ||
IV | 18 | 8 | 44.4 | 4 | 22.2 | 0 | 0 | ||
Pathologic Types | <0.001 | ||||||||
ESS | low malignancy | 24 | 24 | 100.0 | 24 | 100.0 | 20 | 83.3 | |
high malignancy | 14 | 11 | 78.6 | 8 | 57.1 | 5 | 35.7 | ||
Total | 38 | 35 | 92.1 | 32 | 84.2 | 25 | 65.8 | ||
LMS | 22 | 18 | 81.8 | 11 | 50.0 | 5 | 22.7 | ||
CS | 18 | 12 | 66.7 | 7 | 38.9 | 2 | 11.1 | ||
undifferentiated | 2 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Surgery Scope | 0.256 | ||||||||
AH | 79 | 65 | 82.3 | 50 | 63.3 | 31 | 39.2 | ||
AH+BSO | 58 | 48 | 82.8 | 36 | 62.1 | 19 | 32.8 | ||
AH+BSO+PLND | 16 | 13 | 81.3 | 11 | 68.8 | 5 | 31.3 | ||
AH+BSO+OE | 30 | 25 | 83.3 | 20 | 66.7 | 8 | 26.7 | ||
Total | 80 | 65 | 81.3 | 50 | 62.5 | 32 | 40.0 |